HB

Himanshu Bansal

Universitatsklinikum Wurzburg Schwerpunkt und Funktionseinheit Kardiologie, Institute Of Experimental Medicine, King George's Medical University, Aarhus Universitetshospital Nyremedicinsk Afdeling C

ORCID iD 0000-0002-4224-8632

About

Present position
Professor, Division of Surgery, C.H.Medical College Kumaon University India
Consultant, Regenerative Medicine & Scientist Spinal Cord, Neurodegenerative Disorders & Stem Cell research MOTHER CELL & Revita Lifesciences,Uttrakhand.New Delhi, Chennai
Consultant Implant development , Treu-Instrumente, Germany
Raised in Rudrapur, Dr. Himanshu Bansal completed his medical school residency and post graduation from King George Medical College in Lucknow, U.P. During his post graduation, he actively pursued work focused on spinal cord injury and after having subsequently presented his work at variety of forums, he decided to enrich himself by pursuing fellowships in Hip and Knee replacement unit of Aarhus University Hospital at Denmark, Hip replacement unit of Guy's Hospital of Kings College at London and Orthopaedic Traumatology unit of Wurzburg university hospital at Germany & microsurgery at Osaka city university Japan.

Because of his interest for Striving excellence in management of spinal cord injury decided to work exclusively for spinally injured, he undertook various visits and research fellowships in spinal cord regeneration at:

Miami Project to Cure Paralysis (Miami University) USA.
Reeve-Irvine Research Center, California USA.
Queen Elizabeth Spinal Trauma Centre, Glasgow,
Scotland.
Neuroscience Center-Rutgers University USA.
Egaz Monis hospital, lisbon , Portugal.
European spinal cord research institute, Brescia Italy.

In one of his quests for treatments for Spinal Cord Injury worldwide, he got an insight on stem cell application in Spinal Cord and brain injury. This was followed by a formal training in stem cell application in various neurodegenerative disorders at the Institute of experimental medicine Prague, Beatson Institute, university of Glasgow and Saint Gerkatuen Hospital, Germany.

He has developed MRI based classification of Spinal cord injuries and developed a comprehensive treatment with autologous tissue like BM stem cells, dural nerve graft, nasal olfactory tissue and omental transposition after assessment of type and severity of SCI on MRI.

He has built a charitable hospital for orthopedic traumatology at Rudrapur, Uttrakhand, providing charitable treatment to poor masses and also established the first microsurgery unit of the state. He has been successful at inventing new types of cost effective implants to aid in successful fracture surgery outcomes like the patented forearm interlocking nail, locked nail for fracture of lower end radius.

He is currently developing a facility of Institute of Spinal Injury & Stem Cell Research at Rudrapur.

Employment

  • Universitatsklinikum Wurzburg Schwerpunkt und Funktionseinheit Kardiologie Fellow
    2007 - 2007
  • Institute Of Experimental Medicine Fellow
    2007 - 2007
  • Aarhus Universitetshospital Nyremedicinsk Afdeling C Fellow
    2003 - 2003
  • Osaka Isen Research Fellow
    2000 - 2001
  • King George's Medical University Senior Residency
    1997 - 1998

Education

  • King George's Medical University MBBS, MS
    1988 - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (28)

  • Clinical Evaluation of Ultrasonicated ADSCs in Atrophic Non-Union of Long Bones
    medRxiv 2025
    +Save
  • Author correction: platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy
    Scientific Reports 2021
    +Save
  • Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis (Retraction of Vol 15, art no 141, 2017)
    2021
    +Save
  • Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy
    Scientific reports 2021
    +Save
  • Retraction Note to: Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis
    2021
    +Save
  • Clinical Efficacy of a Single-Dose of Platelet Rich Plasma in the Management of Early Knee Osteoarthritis: A Randomized Controlled Study with Mri Assessment and Evaluation of Optimal Dose
    2020
    +Save
  • Do Morphological and Ethnic Factors Affect the Outcome of Total Knee Arthroplasty?-A Review
    J Orthop Res Ther 2020
    +Save
  • Minimally Invasive Technique For Delayed union Or Nonunion# Tibia: The Use Of Percutaneous Autologous Bone Marrow Injection
    Journal of Bone and Joint Diseases 2020
    +Save
  • Impact of the Fibroblast Morphogenetic Field Information on Human Healthy and Tumor Cell Lines In Vitro.
    Journal of Stem Cells 2017
    +Save
  • RETRACTED ARTICLE: Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis
    Journal of translational medicine 2017
    +Save